MeSH term
Frequency | Condition_Probility | Adult | 9 | 0.0 |
Comparative Study | 14 | 0.0 |
Humans | 103 | 0.0 |
Animals | 25 | 0.0 |
Antigens, CD1/*immunology | 12 | 34.0 |
Cell Line | 25 | 0.0 |
Cells, Cultured | 12 | 0.0 |
Female | 11 | 0.0 |
Immunophenotyping | 7 | 0.0 |
Lymphocyte Activation/immunology | 4 | 0.0 |
Mycobacterium tuberculosis/*immunology | 4 | 6.0 |
Research Support, Non-U.S. Gov't | 86 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 41 | 0.0 |
*Antigen Presentation | 12 | 7.0 |
Antigens, Bacterial/immunology | 4 | 3.0 |
Hela Cells | 6 | 0.0 |
Lipids/immunology | 2 | 28.0 |
Macromolecular Substances | 4 | 0.0 |
Protein Transport | 2 | 0.0 |
Antibody Specificity | 4 | 0.0 |
Antigens, CD1/immunology/*metabolism | 2 | 66.0 |
B-Lymphocytes/immunology | 2 | 0.0 |
Cytoplasm/immunology | 4 | 4.0 |
Dendritic Cells/immunology | 3 | 2.0 |
Disease Models, Animal | 3 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Antigen Presentation/*immunology | 10 | 11.0 |
Glycolipids/*immunology | 2 | 12.0 |
Structure-Activity Relationship | 2 | 0.0 |
T-Lymphocytes/immunology | 8 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Amino Acid Sequence | 16 | 0.0 |
Antigens, CD1/*metabolism | 8 | 25.0 |
*Endocytosis | 2 | 1.0 |
Molecular Sequence Data | 18 | 0.0 |
Protein Binding | 2 | 0.0 |
Antigen Presentation | 9 | 2.0 |
Binding Sites | 2 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Flow Cytometry | 8 | 0.0 |
Mice | 10 | 0.0 |
Protein Conformation | 5 | 0.0 |
Protein Folding | 3 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Antigens, CD1/*biosynthesis/genetics | 2 | 100.0 |
Cell Adhesion | 3 | 0.0 |
Down-Regulation | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology | 5 | 1.0 |
Interleukin-4/pharmacology | 5 | 1.0 |
Leukocytes, Mononuclear/*immunology | 3 | 1.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Cell Differentiation | 4 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Ligands | 2 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology | 5 | 3.0 |
Time Factors | 2 | 0.0 |
*Antigen Presentation/genetics | 3 | 20.0 |
Models, Molecular | 6 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
T-Lymphocytes/*immunology/*metabolism | 2 | 6.0 |
Antigen Presentation/immunology | 4 | 5.0 |
Intracellular Fluid/immunology/metabolism | 2 | 6.0 |
T-Lymphocytes/*immunology | 10 | 0.0 |
Aged | 7 | 0.0 |
Middle Aged | 7 | 0.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
Glycolipids/immunology/metabolism | 3 | 100.0 |
Lipids/*metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Antigens, Bacterial/*immunology | 9 | 7.0 |
Antigens, CD/metabolism | 2 | 0.0 |
Antigens, CD1/*immunology/metabolism | 2 | 40.0 |
Lipids/*immunology | 4 | 50.0 |
Antigens, CD1/*biosynthesis | 3 | 30.0 |
Biological Transport/immunology | 2 | 7.0 |
*Lectins, C-Type | 3 | 1.0 |
*Mannose-Binding Lectins | 3 | 6.0 |
Antigens, Bacterial/immunology/metabolism | 2 | 28.0 |
Mycolic Acids/immunology/metabolism | 2 | 100.0 |
Calcium Signaling | 2 | 2.0 |
Child | 4 | 0.0 |
Lymphocyte Activation | 12 | 0.0 |
Superantigens/*immunology | 2 | 2.0 |
T-Lymphocyte Subsets/*immunology | 5 | 0.0 |
*Lymphocyte Activation | 3 | 0.0 |
Monocytes/*immunology | 2 | 0.0 |
Antigens, Bacterial/chemistry/metabolism | 2 | 100.0 |
Autoimmunity | 2 | 1.0 |
Mycobacterium/immunology | 3 | 23.0 |
Endosomes/immunology | 2 | 28.0 |
Antibodies, Monoclonal | 4 | 0.0 |
Antigens, CD4/immunology | 2 | 1.0 |
Lymphocyte Culture Test, Mixed | 2 | 0.0 |
Tetanus Toxoid/immunology | 2 | 2.0 |
Calnexin | 2 | 6.0 |
Transfection | 9 | 0.0 |
Antigens, CD1/*genetics | 2 | 14.0 |
Base Sequence | 11 | 0.0 |
Histocompatibility Antigens Class I/*immunology | 3 | 2.0 |
Histocompatibility Antigens Class II/*immunology | 2 | 1.0 |
Cell Polarity | 2 | 1.0 |
Dogs | 2 | 0.0 |
Endocytosis | 5 | 1.0 |
Microscopy, Electron | 2 | 0.0 |
Interleukin-4/*pharmacology | 3 | 1.0 |
Adolescent | 2 | 0.0 |
Fixatives | 2 | 2.0 |
Receptors, Antigen, T-Cell, gamma-delta/*immunology | 2 | 4.0 |
Antibiotics, Antitubercular/*pharmacology | 2 | 14.0 |
Cell Membrane/immunology | 4 | 1.0 |
Monocytes/immunology | 2 | 0.0 |
Rifampin/*pharmacology | 2 | 4.0 |
Antigens, CD/analysis | 5 | 0.0 |
Antigens, CD1/*analysis | 2 | 9.0 |
Antigens, Differentiation, Myelomonocytic/analysis | 2 | 0.0 |
Male | 8 | 0.0 |
Antigens, CD/immunology | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 3 | 0.0 |
Biological Transport | 2 | 0.0 |
Cell Compartmentation | 2 | 0.0 |
Fluorescent Antibody Technique | 6 | 0.0 |
Microscopy, Immunoelectron | 3 | 0.0 |
Mycobacterium tuberculosis/immunology | 2 | 6.0 |
Mycobacterium leprae/immunology | 2 | 9.0 |
Phosphatidylinositols/immunology | 2 | 66.0 |
beta 2-Microglobulin/*immunology | 2 | 8.0 |
Immunity, Cellular | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 5 | 0.0 |
Endoplasmic Reticulum/*metabolism | 2 | 1.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Rabbits | 3 | 0.0 |
beta 2-Microglobulin/metabolism | 2 | 2.0 |
Antigens, CD1/*physiology | 3 | 30.0 |
CD8-Positive T-Lymphocytes/immunology | 2 | 0.0 |
Lipopolysaccharides/immunology | 2 | 1.0 |
Solubility | 2 | 0.0 |
Cell Differentiation/drug effects | 2 | 0.0 |
Cell Separation | 2 | 0.0 |
CD4-Positive T-Lymphocytes/immunology | 2 | 0.0 |
Cell Division/immunology | 2 | 0.0 |
Dendritic Cells/*immunology | 3 | 1.0 |
Aged, 80 and over | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Rats | 2 | 0.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
Antigens, CD1 | 20 | 21.0 |
Signal Transduction | 3 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Antigens, CD/*immunology | 4 | 0.0 |
Gestational Age | 2 | 0.0 |
Antigens, CD/*genetics | 2 | 0.0 |
Antigens/*analysis | 2 | 2.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Antigen-Presenting Cells/*physiology | 2 | 5.0 |
HLA-DR Antigens/*analysis | 2 | 1.0 |
Skin/cytology/*immunology | 2 | 20.0 |
DNA Primers | 2 | 0.0 |
In Vitro | 2 | 0.0 |
T-Lymphocytes/*immunology/metabolism | 2 | 1.0 |
Antigen-Presenting Cells/immunology | 2 | 0.0 |
Basement Membrane/immunology | 2 | 3.0 |
Langerhans Cells/immunology | 3 | 8.0 |
T-Lymphocyte Subsets/immunology | 2 | 0.0 |
Antigens, CD/*analysis | 2 | 0.0 |
Epidermis/immunology | 2 | 9.0 |
Antigens, Surface/immunology | 2 | 1.0 |
Antigens, Differentiation, T-Lymphocyte/immunology | 2 | 1.0 |
Antigens, CD/analysis/classification | 2 | 100.0 |
Antigens, Differentiation/*analysis/classification | 2 | 100.0 |
Immunoblotting | 2 | 0.0 |
Leukemia/*immunology | 2 | 5.0 |
Tumor Markers, Biological/*analysis/classification | 2 | 66.0 |
Antigens, Differentiation/*analysis | 3 | 1.0 |
Molecular Weight | 4 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Antibodies, Monoclonal/diagnostic use | 2 | 0.0 |
Antigens, Differentiation, B-Lymphocyte/*analysis | 3 | 5.0 |
English Abstract | 2 | 0.0 |
Alleles | 2 | 0.0 |
Thymus Gland/cytology/embryology/*immunology | 2 | 50.0 |
Killer Cells, Natural/immunology | 2 | 0.0 |
